Cibc World Market Inc. Sage Therapeutics, Inc. Transaction History

Cibc World Market Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$138.11 - $169.04 $570,394 - $698,135	-4,130 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$140.36 - $175.76 $81,408 - $101,940	580 Added 16.34%	4,130 $646,000
Q1 2018 May 18, 2018	SELL	$152.15 - $192.33 $133,892 - $169,250	-880 Reduced 19.86%	3,550 $572,000
Q4 2017 Feb 01, 2018	BUY	$60.72 - $167.34 $268,989 - $741,316	4,430	4,430 $730,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $337M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.